ZBH vs. GEHC, PHG, SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, and NARI
Should you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.
Zimmer Biomet vs.
GE HealthCare Technologies (NASDAQ:GEHC) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership.
GE HealthCare Technologies has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.
GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Zimmer Biomet pays out 21.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
GE HealthCare Technologies currently has a consensus price target of $97.67, indicating a potential upside of 6.06%. Zimmer Biomet has a consensus price target of $124.15, indicating a potential upside of 19.79%. Given Zimmer Biomet's higher possible upside, analysts clearly believe Zimmer Biomet is more favorable than GE HealthCare Technologies.
Zimmer Biomet has a net margin of 11.77% compared to GE HealthCare Technologies' net margin of 10.13%. GE HealthCare Technologies' return on equity of 25.74% beat Zimmer Biomet's return on equity.
In the previous week, GE HealthCare Technologies had 9 more articles in the media than Zimmer Biomet. MarketBeat recorded 21 mentions for GE HealthCare Technologies and 12 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.06 beat GE HealthCare Technologies' score of 0.98 indicating that Zimmer Biomet is being referred to more favorably in the news media.
82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Comparatively, 1.0% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Zimmer Biomet received 880 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 67.06% of users gave Zimmer Biomet an outperform vote while only 60.00% of users gave GE HealthCare Technologies an outperform vote.
GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.
Summary
Zimmer Biomet beats GE HealthCare Technologies on 13 of the 21 factors compared between the two stocks.
Get Zimmer Biomet News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zimmer Biomet Competitors List
Related Companies and Tools
This page (NYSE:ZBH) was last updated on 2/21/2025 by MarketBeat.com Staff
